17
Participants
Start Date
July 31, 2010
Primary Completion Date
November 30, 2010
Study Completion Date
August 31, 2013
Imiquimod
"From the group of subjects who met the inclusion criteria, 22 people were selected randomly (using a random number table) since a 20-25% loss to follow up was calculated and the least amount of patients needed were 17.~During the study participants applied imiquimod cream 5% (Virosupril ® laboratories Roemmers) in the periocular area during the night, three times a week, on nonconsecutive days, for 12 weeks (3 months). If patients presented irritative dermatitis a topical 0.05% desonide cream was administered and applied for less of 5 days until symptoms improved."
Centro de servicios CES Sabaneta, Medellín
Lead Sponsor
CES University
OTHER